合成和活动评价的Vinpocetine-Derived 印度醇类化合物
Zhang-Chao Dong1, Yang Shi1, Liang-Liang Zheng1
1College of Pharmacy, Guizhou University of Traditional Chinese Medicine, Guiyang 550025, China.
Molecules (Basel, Switzerland)
|January 11, 2024
概括
合成了新型的温波塞丁衍生物,并对基化酶1A (PDE1A) 抑制进行了评估. 几种衍生品显示出增强的PDE1A抑制活性,其中化合物25特别强,表明药物开发的潜力.
科学领域:
- 药用化学 医学化学
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- 维诺是一种已知的血管扩张剂和神经保护剂.
- 二酶1A (PDE1A) 涉及到各种生理过程.
- 开发新的PDE1A抑制剂具有治疗意义.
研究的目的:
- 为了合成新的温波塞丁衍生物.
- 评估这些衍生物对PDE1A的抑制活性.
- 通过分子对接,阐明强效抑制剂的结合相互作用.
主要方法:
- 合成温波塞丁衍生物 (化合物 2-25).
- 使用NMR (1H, 13C) 和HRMS进行表征.
- 在体外评估PDE1A抑制活性 (IC50确定).
- 选择化合物的分子对接研究 (4和25).
主要成果:
- 化合物3,4,5,12,14,21,和25与文波西丁相比表现出更高的PDE1A抑制活性.
- 化合物4的活性增加了5倍 (IC50 = 3.53μM).
- 化合物25的活性增加了8倍 (IC50 = 2.08μM).
- 分子对接揭示了关键的结合相互作用,包括 π-π 堆叠和结合.
结论:
- 合成的芬波塞丁衍生物具有显著的PDE1A抑制潜力.
- 化合物25是进一步药物开发的一个非常有前途的候选者.
- 分子对接为PDE1A抑制的结构-活性关系提供了宝贵的见解.
相关概念视频
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
978
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
The direct-acting...
978
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
3.0K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.0K
Adrenergic Agonists: Indirect-Acting Agents
1.6K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
1.6K
Direct-Acting Cholinergic Agonists: Pharmacokinetics
1.2K
Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
1.2K


